The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations

por Mishima, Y, Terui, Y, Takeuchi, K, Matsumoto-Mishima, Y, Matsusaka, S, Utsubo-Kuniyoshi, R, Hatake, K
Publicado 2011

Nanomaterials: from research to applications

por Hosono, H, Mishima, Y, Takezoe, H, MacKenzie, K J D
Publicado 2006

High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy

por Kusano, Y, Yokoyama, M, Terui, Y, Inoue, N, Takahashi, A, Yamauchi, H, Tsuyama, N, Nishimura, N, Mishima, Y, Takeuchi, K, Hatake, K
Publicado 2017

Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma

por Kusano, Y, Yokoyama, M, Terui, Y, Nishimura, N, Mishima, Y, Ueda, K, Tsuyama, N, Hirofumi, Y, Takahashi, A, Inoue, N, Takeuchi, K, Hatake, K
Publicado 2017

Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma

por Kusano, Y, Yokoyama, M, Terui, Y, Nishimura, N, Mishima, Y, Ueda, K, Tsuyama, N, Yamauchi, H, Takahashi, A, Inoue, N, Takeuchi, K, Hatake, K
Publicado 2017

Distinct roles of class I PI3K isoforms in multiple myeloma cell survival and dissemination

por Sahin, I, Moschetta, M, Mishima, Y, Glavey, S V, Tsang, B, Azab, F, Manier, S, Zhang, Y, Maiso, P, Sacco, A, Azab, A K, Roccaro, A M, Ghobrial, I M
Publicado 2014

Luminous, relativistic, directional electron bunches from an intense laser driven grating plasma

por Lad, Amit D., Mishima, Y., Singh, Prashant Kumar, Li, Boyuan, Adak, Amitava, Chatterjee, Gourab, Brijesh, P., Dalui, Malay, Inoue, M., Jha, J., Tata, Sheroy, Trivikram, M., Krishnamurthy, M., Chen, Min, Sheng, Z. M., Tanaka, K. A., Kumar, G. Ravindra, Habara, H.
Publicado 2022